
September 18, 2024
Sarama Resources Ltd. (“Sarama” or the “Company”) (ASX:SRR, TSX- V:SWA) is pleased to report that on 18 September 2024, it had completed the issue of shares in part settlement of deferred executive salaries and director fees (the “Compensation Shares” or the “Shares for Debt”) as previously announced in a news release dated 17 July 2024.
The Shares for Debt arrangement comprised the issue of 22,348,980 Chess Depository Instruments (“CDIs”) at a deemed issue price of A$0.02 per CDI, equivalent to A$446,979.60 as detailed in Table 1 below. Each new CDI issued under the Placement will rank equally with existing CDIs on issue and each CDI will represent a beneficial interest in one common share of the Company. The issuance of the Shares for Debt was subject to TSXV and shareholder approval which was obtained at the annual general meeting held on 11 September 2024 (the “Meeting”).

The Compensation Shares and Shares for Debt were issued upon receipt of shareholder approval, as required by the Australian Securities Exchange Listing Rules, at the Meeting. An Appendix 2A was announced to the ASX on 18 September 2024 and provides further detail on the issue of the Compensation Shares and Shares for Debt.
The Share for Debt arrangement will reduce the Company’s liabilities.
The CDIs issued under the Placement are subject to a TSX Venture Exchange (“TSXV”) “hold period” of 4 months and one day from the date of issue of the CDIs.
The Securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended, (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from registration is available. This announcement does not constitute an offer to sell or a solicitation of an offer to buy any of the Securities within the United States or to, or for the account or benefit of, U.S. Persons (as defined under Regulation S under the U.S. Securities Act), nor shall there be any sale of these Securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Click here for the full ASX Release
This article includes content from Sarama Resources, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
SRR:AU

Sign up to get your FREE
Sarama Resources Investor Kit
and hear about exciting investment opportunities.
- Corporate info
- Insights
- Growth strategies
- Upcoming projects
GET YOUR FREE INVESTOR KIT
INN Article Notification
The Conversation (0)
04 November 2025
Sarama Resources
Promising new gold projects in Western Australia, plus a large fully funded arbitration claim.
Promising new gold projects in Western Australia, plus a large fully funded arbitration claim. Keep Reading...
29 May
Completion of Tranche 1 Equity Placement & Cleansing Notice
Sarama Resources (SRR:AU) has announced Completion of Tranche 1 Equity Placement & Cleansing NoticeDownload the PDF here. Keep Reading...
20 May
Sarama Raises A$1.5m in Private Placement
Sarama Resources (SRR:AU) has announced Sarama Raises A$1.5m in Private PlacementDownload the PDF here. Keep Reading...
18 May
Trading Halt
Sarama Resources (SRR:AU) has announced Trading HaltDownload the PDF here. Keep Reading...
15 May
Q1 2026 Interim Financial Statements
Sarama Resources (SRR:AU) has announced Q1 2026 Interim Financial StatementsDownload the PDF here. Keep Reading...
15 May
Qtly Activities Report - Q1 26 Mgmt's Discussion & Analysis
Sarama Resources (SRR:AU) has announced Qtly Activities Report - Q1 26 Mgmt's Discussion & AnalysisDownload the PDF here. Keep Reading...
2h
Precious Metals News: Gold, Silver, PGMs Prices Slide as Investors Brace for Fed Meeting
Precious metals prices are staring down the barrel of next week's US Federal Reserve meeting Justification for higher interest rates is rising, and prices for gold, platinum and palladium are bowing down to levels not seen since the fall of 2025. Meanwhile, silver has fallen back to a range it... Keep Reading...
5h
Northern Star Faces Investor Pressure for Strategic Review
Activist investor Elliott Investment Management sharpened its attack against Northern Star Resources (ASX:NST,OTCPL:NESRF) on Wednesday (June 10), claiming that the Australian gold miner’s board fails to grasp the depth of its operational crisis and must immediately launch a formal strategic... Keep Reading...
10 June
Don Hansen: Gold, Silver Stock Analysis, Plus What's Next for Prices
Private investor Don Hansen outlines his latest thoughts on gold and silver, explaining how historical data shows higher prices are still to come. He also goes over his updated gold and silver stock analysis, including how his portfolio performed during the recent run in precious metals... Keep Reading...
09 June
iMetal Resources Announces Non-Brokered Private Placement
iMetal Resources Inc. (TSXV: IMR,OTC:IMRFF) (OTCQB: IMRFF) (FSE: A7VA) ("iMetal" or the "Company") is pleased to announce that it will offer (the "Offering") up to 40,000,000 units (each, a "Unit") at a price of $0.10 per Unit, by way of non-brokered private placement, for gross proceeds of up... Keep Reading...
09 June
Court Validates Seabridge Gold’s Work Status on Stalled KSM Project
Seabridge Gold (TSX:SEA,NYSE:SA) has secured a favorable but conditional ruling from the BC Supreme Court regarding the development status of its long-stalled KSM project.The court has upheld the BC Environmental Assessment Office’s (EAO) determination that Seabridge had "substantially started"... Keep Reading...
Latest News

Sign up to get your FREE
Sarama Resources Investor Kit
and hear about exciting investment opportunities.
- Corporate info
- Insights
- Growth strategies
- Upcoming projects
GET YOUR FREE INVESTOR KIT
Interactive Chart
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00







